GSK employees admit to bribery, tax violations, China says

07/12/2013 | Reuters

GlaxoSmithKline executives who are being investigated in China for alleged bribery and tax-related violations have already admitted to the offenses, China's Ministry of Public Security said Thursday. The suspects are believed to have used fake receipts to commit unspecified tax law violations and to have offered large bribes to Chinese government officials, doctors, hospitals and medical associations to increase prices and sales. GSK has expressed willingness to cooperate with authorities, saying it takes "all allegations of bribery and corruption seriously."

View Full Article in:


Published in Brief: